TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Olink Proteomics AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
989,720
|
907,295
|
567,226 |
| Financial expenses |
32,787
|
3,164
|
5 |
| Earnings before taxes |
-60,490
|
3,063
|
-62,458 |
| EBITDA |
-10,046
|
16,302
|
-55,875 |
| Total assets |
1,259,439
|
839,329
|
742,208 |
| Current assets |
716,730
|
607,262
|
539,898 |
| Current liabilities |
190,621
|
586,828
|
470,568 |
| Equity capital |
1,068,818
|
252,501
|
271,640 |
| - share capital |
34
|
33
|
36 |
| Employees (average) |
362
|
289
|
183 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
84.9%
|
30.1%
|
36.6% |
| Turnover per employee |
2,734
|
3,139
|
3,100 |
| Profit as a percentage of turnover |
-6.1%
|
0.3%
|
-11.0% |
| Return on assets (ROA) |
-2.2%
|
0.7%
|
-8.4% |
| Current ratio |
376.0%
|
103.5%
|
114.7% |
| Return on equity (ROE) |
-5.7%
|
1.2%
|
-23.0% |
| Change turnover |
77,752
|
386,015
|
209,612 |
| Change turnover % |
9%
|
74%
|
59% |
| Chg. No. of employees |
73
|
106
|
53 |
| Chg. No. of employees % |
25%
|
58%
|
41% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.